| The Company holds the exclusive licenses for six granted US patents and one PCT patent from Brookhaven National Laboratories.
Psimei’s intellectual property covers composition of matter, manufacturing processes and formulations and the Company has offensive/defensive positions in second and third generation PAT (and Boron Neutron Capture Therapy candidates).
Our IP advisers are:
Kilburn and Strode (London) www.kstrode.co.uk
Elkington and Fife (London) www.elkfife.com
Hoffman Baron (New York) www.hoffmanbaron.com
|
